Department of thoracic surgery, Guangzhou Panyu Central Hospital, Guangzhou, PR China.
PLoS One. 2020 Feb 24;15(2):e0229118. doi: 10.1371/journal.pone.0229118. eCollection 2020.
Long noncoding RNA activated by transforming growth factor-β (lncRNA-ATB) plays a critical role in progression of several cancers. In this study, lncRNA-ATB was significantly up-regulated in NSCLC tissues and cell lines, and high lncRNA-ATB expression indicated poor prognosis. Knockdown of lncRNA-ATB suppressed NSCLC cell growth, colony formation, migration, invasion and reversed epithelial-mesenchymal transition. In vivo study showed that silencing lncRNA-ATB inhibited tumor growth. Further mechanism studies demonstrated that lncRNA-ATB was a target of miR-141-3p. MiR-141-3p expression was negatively related to lncRNA-ATB expression in NSCLC tissues. These results suggested that inhibiting lncRNA-ATB might be an approach for NSCLC treatment.
转化生长因子-β激活的长非编码 RNA(lncRNA-ATB)在多种癌症的进展中发挥着关键作用。在本研究中,lncRNA-ATB 在 NSCLC 组织和细胞系中显著上调,并且高表达 lncRNA-ATB 预示着不良预后。lncRNA-ATB 的敲低抑制了 NSCLC 细胞的生长、集落形成、迁移和侵袭,并逆转了上皮-间充质转化。体内研究表明,沉默 lncRNA-ATB 抑制了肿瘤生长。进一步的机制研究表明,lncRNA-ATB 是 miR-141-3p 的靶标。miR-141-3p 的表达与 NSCLC 组织中 lncRNA-ATB 的表达呈负相关。这些结果表明,抑制 lncRNA-ATB 可能是 NSCLC 治疗的一种方法。